Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Turvill

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Frontline Gastroenterology|August 26, 2017
High negative predictive value of a normal faecal calprotectin in patients with symptomatic intestinal diseaseJames Turvill
Frontline Gastroenterology|August 26, 2017
Mapping of Crohn's disease outcomes to faecal calprotectin levels in patients maintained on biologic therapyJames Turvill
Frontline Gastroenterology|June 27, 2020
Audit of the impact of the York faecal calprotectin care pathway on colonoscopy activityJames Turvill, Daniel Turnock
Expert Review of Pharmacoeconomics & Outcomes Research|April 7, 2020
Evaluation of the Cost-Utility of the York Faecal Calprotectin Care PathwayHayden Holmes, Jessica McMaster, Heather Davies, et al.
Scandinavian Journal of Gastroenterology|January 10, 2019
Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancerJames Turvill, Samantha Mellen, Laura Jeffery, et al.
Annals of Clinical Biochemistry|March 15, 2018
Evaluation of sample stability for a quantitative faecal immunochemical test and comparison of two sample collection approachesSamantha Mellen, Maria de Ferrars, Claire Chapman, et al.
Therapeutic Advances in Gastrointestinal Endoscopy|March 30, 2026
Patient experiences of colon capsule endoscopy: a qualitative studyLaura Jefferson, Holly Essex, Karl Atkin, et al.
Frontline Gastroenterology|September 25, 2018
Evaluation of the clinical and cost-effectiveness of the York Faecal Calprotectin Care PathwayJames Turvill, Daniel Turnock, Hayden Holmes, et al.
Frontline Gastroenterology|August 26, 2017
Validation of a care pathway for the use of faecal calprotectin in monitoring patients with Crohn's diseaseJames Turvill, Lisa Rook, Maxine Rawle, et al.
Cancers|October 14, 2022
A Multi-Centre Study to Risk Stratify Colorectal Polyp Surveillance Patients Utilising Volatile Organic Compounds and Faecal Immunochemical TestSubashini Chandrapalan, Farah Khasawneh, Baljit Singh, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontline Gastroenterology|August 26, 2017
High negative predictive value of a normal faecal calprotectin in patients with symptomatic intestinal diseaseJames Turvill
Frontline Gastroenterology|August 26, 2017
Mapping of Crohn's disease outcomes to faecal calprotectin levels in patients maintained on biologic therapyJames Turvill
Frontline Gastroenterology|June 27, 2020
Audit of the impact of the York faecal calprotectin care pathway on colonoscopy activityJames Turvill, Daniel Turnock
Expert Review of Pharmacoeconomics & Outcomes Research|April 7, 2020
Evaluation of the Cost-Utility of the York Faecal Calprotectin Care PathwayHayden Holmes, Jessica McMaster, Heather Davies, et al.
Scandinavian Journal of Gastroenterology|January 10, 2019
Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancerJames Turvill, Samantha Mellen, Laura Jeffery, et al.
Annals of Clinical Biochemistry|March 15, 2018
Evaluation of sample stability for a quantitative faecal immunochemical test and comparison of two sample collection approachesSamantha Mellen, Maria de Ferrars, Claire Chapman, et al.
Therapeutic Advances in Gastrointestinal Endoscopy|March 30, 2026
Patient experiences of colon capsule endoscopy: a qualitative studyLaura Jefferson, Holly Essex, Karl Atkin, et al.
Frontline Gastroenterology|September 25, 2018
Evaluation of the clinical and cost-effectiveness of the York Faecal Calprotectin Care PathwayJames Turvill, Daniel Turnock, Hayden Holmes, et al.
Frontline Gastroenterology|August 26, 2017
Validation of a care pathway for the use of faecal calprotectin in monitoring patients with Crohn's diseaseJames Turvill, Lisa Rook, Maxine Rawle, et al.
Cancers|October 14, 2022
A Multi-Centre Study to Risk Stratify Colorectal Polyp Surveillance Patients Utilising Volatile Organic Compounds and Faecal Immunochemical TestSubashini Chandrapalan, Farah Khasawneh, Baljit Singh, et al.
Pageof 2